Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Morimoto S, Takahashi S, Ito D, Date Y, et al. Cell Stem Cell 2023;30:766-780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Morimoto S, Takahashi S, Ito D, Date Y, et al. Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell 2023;30:766-780.
PMID: 37267913